Bonus Share Details

  • Recommended bonus issue ratio: 1:1 (one new equity share for each existing fully paid-up equity share)
  • Existing authorized equity share capital: ₹20,00,00,000
  • Existing paid-up equity share capital: ₹16,61,44,570
  • Post-bonus paid-up equity share capital: ₹33,22,89,140
  • Number of equity shares post-bonus: 6,64,57,828 shares of face value ₹5 each
  • Record date: To be announced after shareholders' approval

Financial Position

  • Reserves & Surplus (India) as at March 31, 2026: ₹655 crores
  • Company clarifies the bonus issue will not impact solvency margin or other financial parameters

Management Appointment

  • Board proposed appointment of Mr. Janumahanti Rana Pratap as Director - Marketing and Strategy
  • Qualifications: Alumnus of IIT Delhi and IIM Lucknow
  • Experience: Associated with company for 14 years, played important role in marketing initiatives and pharmaceutical packaging business

Rationale and Context

  • Marks company's four-decade growth journey
  • Intended as appreciation for shareholder trust and support
  • Aims to broaden retail investor participation
  • Enhance liquidity of equity shares
  • Make shares more accessible and affordable to wider investor base
  • Part of leadership transition planning combining experience with next generation capabilities